oxcarbazepin orion 600 mg tabletti, kalvopäällysteinen
orion corporation - oxcarbazepine - tabletti, kalvopäällysteinen - 600 mg - okskarbatsepiini
lacosamide accord
accord healthcare s.l.u. - lakosamidi - epilepsia - epilepsialääkkeet, - lacosamide accord is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. lacosamide accord is indicated as adjunctive therapy• in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. • in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.
bimatoprost stada 0.3 mg/ml silmätipat, liuos, kerta-annospakkaus
stada arzneimittel ag - bimatoprost - silmätipat, liuos, kerta-annospakkaus - 0.3 mg/ml - bimatoprosti
lacosamide adroiq
extrovis eu ltd. - lakosamidi - epilepsia - epilepsialääkkeet, - lacosamide adroiq is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. lacosamide adroiq is indicated as adjunctive therapyin the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.
norgesic 35 mg / 450 mg tabletti
viatris oy - orphenadrine citrate, paracetamol - tabletti - 35 mg / 450 mg - orfenadriini
bricanyl turbuhaler 0.5 mg/annos inhalaatiojauhe
astrazeneca oy - terbutaline sulfate - inhalaatiojauhe - 0.5 mg/annos - terbutaliini
bricanyl turbuhaler 0.25 mg/annos inhalaatiojauhe
astrazeneca oy - terbutaline sulfate - inhalaatiojauhe - 0.25 mg/annos - terbutaliini
havrix 1440 elisa u/ml injektioneste, suspensio
glaxosmithkline biologicals sa - hepatiitti a-virus, kokovirus, inaktivoitu - injektioneste, suspensio - 1440 elisa u/ml - inaktivoitu hepatiitti a -rokote (koko virus)
typhim vi 25 mikrog / 0.5 ml injektioneste, liuos, esitäytetty ruisku
sanofi pasteur europe - salmonella typhi (ty2) bakteerit, vi polysakkaridi - injektioneste, liuos, esitäytetty ruisku - 25 mikrog / 0.5 ml - lavantautipolysakkaridirokote
avaxim injektioneste, suspensio, esitäytetty ruisku
sanofi pasteur europe - hepatiitti a-virus (gbm), kokovirus, inaktivoitu - injektioneste, suspensio, esitäytetty ruisku - 160 u / 0,5 ml - inaktivoitu hepatiitti a -rokote (koko virus)